Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.

Wei TangZhujun CaoMingfeng HanZhengyan WangJunwen ChenWenjin SunYaojie WuWei XiaoShengyong LiuErzhen ChenWei ChenXiongbiao WangJiuyong YangJun LinQingxia ZhaoYouqin YanZhibin XieDan LiYaofeng YangLeshan LiuJieming QuGuang NingGuochao ShiQing Xie

Published in: BMJ (Clinical research ed.) (2020)

ChiCTR2000029868.

Keyphrases

coronavirus disease
open label
study protocol
randomized controlled trial
phase ii
clinical trial
phase iii
phase ii study
respiratory syndrome coronavirus
double blind
squamous cell carcinoma
placebo controlled